Guggenheim Securities Upgrades Medtronic to Buy, Announces $135 Price Target

Guggenheim Securities analyst Christopher Pasquale upgrades Medtronic (NYSE:MDT) from Neutral to Buy and announces $135 price target.

Benzinga · 01/02/2020 12:09

Guggenheim Securities analyst Christopher Pasquale upgrades Medtronic (NYSE:MDT) from Neutral to Buy and announces $135 price target.